Clopidogrel and aspirin in the prevention of thromboembolic complications after mechanical aortic valve replacement (CAPTA)

Thrombosis Research

Volumn 109, Issue 2-3, 2003, Pages 131-135

  Schlitt, Axel ^a   Von Bardeleben, Ralf S ^a   Ehrlich, Anne ^a   Eimermacher, Antje ^a   Peetz, Dirk ^a   Dahm, Manfred ^a   Rupprecht, Hans J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Aspirin; Clopidogrel; Mechanical valve replacement; Oral anticoagulation

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; NADROPARIN; UROKINASE;

ADULT; AGED; ANTICOAGULANT THERAPY; AORTA VALVE DISEASE; AORTA VALVE REPLACEMENT; ARTICLE; BLOOD FLOW; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DYSPNEA; EDEMA; EPIGASTRIC PAIN; FEMALE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; PATHOPHYSIOLOGY; PETECHIA; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STENT; SYSTOLIC HEART MURMUR; THROMBOEMBOLISM;

EID: 0037464819     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(03)00143-9     Document Type: Article

References (12)

1. Cannegieter S.C., Torn M., Rosendaal F.R. Oral anticoagulant treatment in patients with mechanical heart valves: how to reduce the risk of thromboembolic and bleeding complications. J. Intern. Med. 245(4):1999;369-374.
2. Palareti G., Hirsh J., Legnani C., Manotti C., D'Angelo A., Pengo V.et al. Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study. Arch. Intern. Med. 160(4):2000;470-478.
3. Schühlen H., Hadamitzky M., Walter H., Ulm K., Schömig A. Major benefits from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement. Circulation. 95(8):1997;2015-2021.
4. Urban P., Macaya C., Rupprecht H.J., Kiemeneij F., Emanuelson H., Fontanelli A.et al. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients. Circulation. 98:1998;2126-2132.
5. Bertrand M.E., Rupprecht H.J., Urban P., Gershlick A.H. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation. 102(6):2000;624-629.
6. Aramendi J.L., Agredo J., Llorente A., Larrarte C., Pijoan J. Prevention of thromboembolism with ticlopidine shortly after valve repair or replacement with a bioprosthesis. J. Heart Valve Dis. 7(6):1998;610-614.
7. Schlitt A., Hauroeder B., Buerke M., Peetz D., Victor A., Hundt F.et al. Effects of combined therapy of clopidogrel and aspirin in preventing thrombus formation on mechanical heart valves in an ex vivo rabbit model. Thromb. Res. 107(1-2):2002;39-43.
8. Czer L.S.C., Matloff J.M., Chaux A., DeRobertis R.N., Gray R.J. Comparative clinical experience with porcine bioprosthetic and St. Jude valve replacement. Chest. 91(4):1987;503-514.
9. Ribeiro P.A., Al Zaibag M., Idris M., Al Kasab S., Davies G., Mashat E.et al. Antiplatelet drugs and the incidence of thrombembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease. J. Thorac. Cardiovasc. Surg. 91:1986;92-98.
10. Saitoh H., Matsumoto H., Takayama T., Miyawaki F., Furuse A. Evaluation of antiplatelet drugs on platelet functions - comparison between ticlopidine and dipyridamol after prosthetic valve replacement. Kokyu To Junkan. 37(1):1989;87-92.
11. Vongpatanasin W., Hillis L.D., Lange R.A. Prosthetic heart valves. N. Engl. J. Med. 335:1996;407-416.
12. Kastrati A., Koch W., Gawaz M., Mehili J., Bottiger C., Schomig K.et al. PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement. J. Am. Coll. Cardiol. 36(1):2000;84-89.